Comorbidity and frailty assessment in renal cell carcinoma patients.
Jean CourcierAlexandre De La TailleNathalie LassauAlexandre IngelsPublished in: World journal of urology (2021)
Comorbidity and frailty have to be assessed at any stage of the RCC disease based on a standardized scoring system to define the most suitable treatment strategy ranging from surveillance to aggressive treatment.